Konica Minolta Precision Medicine Announces 5-Year Collaboration with Amazon Web Services

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

March 10, 2021

Konica Minolta Precision Medicine, Inc. notes Amazon Web Services (AWS) is their preferred cloud provider, will support the build-out of the company’s LATTICE™ initiative globally.

LATTICE™ is a groundbreaking integrated diagnostic data platform that combines genomics, pathology, and radiology data along with other critical information to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests. As part of this collaboration, Amazon has made a financial investment in Konica Minolta Precision Medicine.

“One of the most significant challenges to the advancement of precision medicine has been the lack of an infrastructure to support translational bioinformatics,” said Kiyotaka Fujii, Chairman of Konica Minolta Precision Medicine. “With LATTICE™, Konica Minolta Precision Medicine will be able to help our customers use the power of these unique datasets to find novel associations and signals.  Leveraging the breadth and depth of AWS services, as well as its secure infrastructure, the company will be better positioned to innovate, collaborating with our expert team of data scientists, developers, clinicians, and pharmaceutical partners at scale, and reducing the time it takes to move from insight to discovery.”

Konica Minolta Precision Medicine is committed to advancing precision medicine for populations and individuals now and in the future. The breadth and agility of LATTICE™ will support global customers with clinical trials at scale and develop new ways to bring clinical grade diagnostic tools directly to researchers and clinicians. LATTICE™ combines KMPM’s cutting edge science with the power of AWS to accelerate drug discovery by leveraging machine learning services, such as Amazon HealthLake, along with AWS storage, compute, database, and analytics services, to help clinicians deliver the right care, to the right patient, at the right time. KMPM will also leverage AWS’s secure infrastructure to process, maintain, and store Protected Health Information (PHI) and comply with Medical Information Guidelines in Japan.

“One of the cornerstones of precision medicine is precision diagnostics, and we are excited to collaborate with Konica Minolta Precision Medicine to enhance and accelerate their innovative offerings and help deliver precision diagnosis at a global scale using Amazon HealthLake,” said Taha Kass-Hout, Director of Machine Learning at AWS. “We’re seeing a renaissance in the healthcare and life sciences industry as more organizations leverage cloud technology on AWS to uncover new ways to reduce cost, improve patient outcomes, and ultimately save lives.”

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.